Stocks & Investing
Stocks and Investing
Stocks and Investing 
Thu, January 6, 2011
Wed, January 5, 2011
Market Maker Surveillance Report. MI, EWJ, STD, BSX, VWO, EEM, Bearishly Biased Price Friction For Wednesday, January 5th 2011
January 5, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 2504 companies with "abnormal" market making, 3314 companies with positive Friction Factors and 2045 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. MARSHALL & ILSLEY CORP (NYSE:MI), ISHARES MSCI JAPAN INDEX FD (NYSE:EWJ), BANCO SANTANDER SA-SPON ADR (NYSE:STD), BOSTON SCIENTIFIC CORP (NYSE:BSX), VANGUARD EMERGING MARKET ETF (NYSE:VWO), ISHARES MSCI EMERGING MKT IN (NYSE:EEM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
MI $-0.050 -0.75% 12,218,101 53.42% 9,768,988 42.71% 2,449,113 Abnormal
EWJ $-0.080 -0.73% 18,496,441 58.32% 13,839,958 43.64% 4,656,483 Abnormal
STD $-0.250 -2.34% 8,349,140 61.64% 4,389,732 32.41% 3,959,408 Abnormal
BSX $-0.040 -0.51% 12,877,232 49.43% 9,878,154 37.92% 2,999,078 Abnormal
VWO $-0.210 -0.43% 11,137,027 56.31% 8,771,311 44.35% 2,365,716 Abnormal
EEM $-0.090 -0.19% 28,335,974 59.62% 20,043,227 42.17% 8,292,747 Abnormal
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more buying than selling on Wednesday and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows EEM with 8,292,747 greater shares of buying than selling (NetVol) and the stock price was down $-0.09000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.
MARSHALL & ILSLEY CORP (NYSE:MI) - Marshall & Ilsley Corporation, through its subsidiaries, provides diversified financial services to corporate, institutional, government, and individual customers in the United States. Its Commercial Banking segment provides various products and services, including secured and unsecured loans and lines of credit, letters of credit, asset-based lending, equipment financing, mezzanine financing, global trade services, treasury management, demand deposit accounts, interest bearing accounts, and time deposits, as well as construction loans for commercial and residential development, and land acquisition and development loans. The companys Community Banking segment provides consumer and business banking products and services comprising loan and deposit products, such as mortgages, home equity loans and lines, credit cards, student loans, personal lines of credit and term loans, demand deposit accounts, interest bearing transaction accounts, and time deposits, as well as loans for working capital, inventory, and general corporate use; commercial real estate construction loans; and agricultural loans. Its Wealth Management segment provides asset management, trust, and banking services, as well as offers retirement plan services, Taft-Hartley services, not-for-profit services, north star deferred exchange, and trust operations outsourcing services. The company also provides derivative solutions and investment services, currency conversion and foreign exchange services, and risk management to corporate, business banking, and financial institution clients. As of December 31, 2009, it operated 162 branch offices in Phoenix and Tucson, Arizona metropolitan areas, Kansas City and nearby communities, Floridas west coast and Orlando, Florida, Minneapolis/St. Paul and Duluth, Minnesota, and central Indiana; and 17 offices in the St. Louis metropolitan area. The company was founded in 1847 and is headquartered in Milwaukee, Wisconsin.
ISHARES MSCI JAPAN INDEX FD (NYSE:EWJ) - ISHARE MSCI JAPAN
BANCO SANTANDER SA-SPON ADR (NYSE:STD) - Banco Santander, S.A. provides various financial products and services in Spain, the United Kingdom, Portugal, other European countries, Latin America, and the United States. It operates through three segments: Retail Banking, Global Wholesale Banking, and Asset Management and Insurance. The Retail Banking segment offers a range of deposit products, including savings, current, demand, time, and notice deposits, as well as international and domestic interbank deposits; and loan products and services, such as auto financing, personal loans, mortgages, and leasing and renting. This segment also offers credit cards, automated cash dispensers, savings books updaters, telephone banking, and electronic and Internet banking. The Global Wholesale Banking segment provides corporate banking, treasury, and investment banking services. Its products and services include commercial financing, funds, trade finance, transactional products, custody services, corporate finance, structured finance, and capital structuring. This segment also engages in the trading and distribution of equities. The Asset Management and Insurance segment involves in the design and management of mutual and pension funds, and insurance products. As of December 31, 2009, the company had 5,871 branch offices in Continental Europe; 1,322 branches in the United Kingdom; 5,745 branches in Latin America; and 722 branches in the Sovereign. The company was founded in 1857 and is headquartered in Madrid, Spain.
BOSTON SCIENTIFIC CORP (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers cardiac rhythm management products, which monitor the heart and deliver electricity to treat cardiac abnormalities; and RF generators, intracardiac ultrasound and steerable ablation catheters, and diagnostic catheters for the diagnosis and treatment of cardiac arrhythmias. The company also provides interventional cardiology products, such as coronary stent systems, coronary revascularization products to treat patients with atherosclerosis and intraluminal catheter-directed ultrasound imaging catheters and systems; vascular access products, balloon catheters, stents and peripheral vascular catheters, wires, and accessories, as well as products for peripheral embolization procedures; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease various forms of benign and malignant tumors. In addition, it offers coated and uncoated detachable coils, micro-delivery stents, micro-guidewires, micro-catheters, guiding catheters, and embolics to neuro-interventional radiologists and neurosurgeons to treat diseases of the neurovascular system; and endoscopy and interventional bronchoscopy products to diagnose and treat various digestive diseases, as well as pulmonary disease systems within the airway and lungs. Further, the company provides urology/womens health products to treat patients with urinary stone disease, benign prostatic hyperplasia, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding; and spinal cord stimulation system for the management of chronic intractable pain of the trunk and/or limbs. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France.
VANGUARD EMERGING MARKET ETF (NYSE:VWO) - VANGRD EMRG MKT V
ISHARES MSCI EMERGING MKT IN (NYSE:EEM) - ISHARES MSCI E.M.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net